Pharma Deals Review, Vol 2002, No 28 (2002)

Font Size:  Small  Medium  Large

Key Oncologics to Market Eligard™ in South Africa

Business Review Editor

Abstract


Atrix Laboratories signed an agreement providing Key Oncologics with the South African marketing rights for its Eligard™ (injectable leuprolide acetate suspension) prostate cancer products.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.